Quantum Biopharma (QNTM) Retained Earnings (2018 - 2026)
Quantum Biopharma (QNTM) posted Retained Earnings of -$211.8 million for Q1 2026, down 6.84% sequentially from -$198.3 million in Q4 2025, and down 17.24% YoY from -$256.0 million in Q1 2025.
Quantum Biopharma (QNTM) Retained Earnings (2018 - 2026) Analysis & Trends
Quantum Biopharma has reported Retained Earnings for 9 years, with the latest figure at -$211.8 million in Q1 2026.
- Quarterly Retained Earnings fell 17.24% year-over-year to -$211.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$211.8 million (down 17.24% YoY) and the FY2025 annual result came in at -$198.3 million, down 15.21% from the prior year.
- Retained Earnings declined to -$211.8 million in Q1 2026 per QNTM's latest filing, from -$198.3 million in the prior quarter.
- Over five years, Retained Earnings peaked at -$127.8 million in Q1 2022 and troughed at -$211.8 million in Q1 2026.
- A 5-year average of -$165.4 million and a median of -$162.9 million in 2024 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2022 and 2024: Retained Earnings declined 26.77% in 2022, then decreased 4.84% in 2024.
- Over 5 years, Retained Earnings stood at -$144.2 million in 2022, then fell by 8.56% to -$156.5 million in 2023, then declined by 9.97% to -$172.1 million in 2024, then retreated by 15.21% to -$198.3 million in 2025, then slipped by 6.84% to -$211.8 million in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered -$211.8 million, -$198.3 million, and -$195.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -6.33 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 20.91 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.57 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 4.38 Bn |
| 10 | Quantum Biopharma | 15.44 Mn | 11.80 Mn | - | -215.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -215.10 Mn |
| Mar 31, 2026 | -211.85 Mn |
| Dec 31, 2025 | -198.29 Mn |
| Sep 30, 2025 | -195.26 Mn |
| Jun 30, 2025 | -189.94 Mn |
| Mar 31, 2025 | -180.69 Mn |
| Dec 31, 2024 | -172.11 Mn |
| Sep 30, 2024 | -166.75 Mn |
| Jun 30, 2024 | -162.92 Mn |
| Sep 30, 2023 | -156.50 Mn |
| Jun 30, 2023 | -155.40 Mn |
| Mar 31, 2023 | -149.91 Mn |
| Dec 31, 2022 | -144.16 Mn |
| Sep 30, 2022 | -138.02 Mn |
| Jun 30, 2022 | -131.53 Mn |
| Mar 31, 2022 | -127.80 Mn |
| Dec 31, 2021 | -126.15 Mn |
| Sep 30, 2021 | -119.81 Mn |
| Jun 30, 2021 | -114.02 Mn |
| Mar 31, 2021 | -100.81 Mn |